Cargando…

Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer

Understanding the relationship between the coexistence of inflammatory and neoplastic processes in ovarian cancer, particularly those involving chemokines and their receptors, may help to elucidate the involvement of the studied parameters in tumor pathogenesis and could lead to improved clinical ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Smycz-Kubańska, Marta, Stępień, Sebastian, Gola, Joanna Magdalena, Kruszniewska-Rajs, Celina, Wendlocha, Dominika, Królewska-Daszczyńska, Patrycja, Strzelec, Anna, Strzelczyk, Jarosław, Szanecki, Wojciech, Witek, Andrzej, Mielczarek-Palacz, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435018/
https://www.ncbi.nlm.nih.gov/pubmed/35920183
http://dx.doi.org/10.3892/mmr.2022.12812
_version_ 1784781017974833152
author Smycz-Kubańska, Marta
Stępień, Sebastian
Gola, Joanna Magdalena
Kruszniewska-Rajs, Celina
Wendlocha, Dominika
Królewska-Daszczyńska, Patrycja
Strzelec, Anna
Strzelczyk, Jarosław
Szanecki, Wojciech
Witek, Andrzej
Mielczarek-Palacz, Aleksandra
author_facet Smycz-Kubańska, Marta
Stępień, Sebastian
Gola, Joanna Magdalena
Kruszniewska-Rajs, Celina
Wendlocha, Dominika
Królewska-Daszczyńska, Patrycja
Strzelec, Anna
Strzelczyk, Jarosław
Szanecki, Wojciech
Witek, Andrzej
Mielczarek-Palacz, Aleksandra
author_sort Smycz-Kubańska, Marta
collection PubMed
description Understanding the relationship between the coexistence of inflammatory and neoplastic processes in ovarian cancer, particularly those involving chemokines and their receptors, may help to elucidate the involvement of the studied parameters in tumor pathogenesis and could lead to improved clinical applications. Therefore, the present study aimed to analyze the levels of C-X-C motif chemokine ligand 8 (CXCL8), and its receptors C-X-C chemokine receptor (CXCR)1 and CXCR2, in the serum and peritoneal fluid of women with ovarian cancer, and to evaluate the association between the expression of these parameters in tumor tissue and patient characteristics, particularly the degree of histological differentiation. The study group included women with ovarian cancer diagnosed with serous cystadenocarcinoma International Federation of Gynecology and Obstetrics stage IIIc and a control group, which consisted of women who were diagnosed with a benign lesion (serous cystadenoma). The transcript levels of CXCL8, CXCR1 and CXCR2 were evaluated using reverse transcription-quantitative PCR (RT-qPCR). The quantitative analysis was carried out using the LightCycler(®) 480 System and GoTaq(®) 1-Step RT-qPCR System, according to the manufacturers' instructions. The concentration of CXCL8 in serum and peritoneal fluid was determined using a Human Interleukin-8 ELISA kit, and the concentrations of CXCR1 and CXCR2 were determined using the CLOUD-CLONE ELISA kit. Local and systemic disturbances in immune and inflammatory responses involving the CXCL8 chemokine and its receptors indicated the involvement of these studied parameters in the pathogenesis of ovarian cancer. Immunoregulation of the CXCL8-CXCR1 system may influence the course of the inflammatory process accompanying ovarian cancer development, which may result in the identification of novel clinical applications; however, further studies are required.
format Online
Article
Text
id pubmed-9435018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-94350182022-09-06 Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer Smycz-Kubańska, Marta Stępień, Sebastian Gola, Joanna Magdalena Kruszniewska-Rajs, Celina Wendlocha, Dominika Królewska-Daszczyńska, Patrycja Strzelec, Anna Strzelczyk, Jarosław Szanecki, Wojciech Witek, Andrzej Mielczarek-Palacz, Aleksandra Mol Med Rep Articles Understanding the relationship between the coexistence of inflammatory and neoplastic processes in ovarian cancer, particularly those involving chemokines and their receptors, may help to elucidate the involvement of the studied parameters in tumor pathogenesis and could lead to improved clinical applications. Therefore, the present study aimed to analyze the levels of C-X-C motif chemokine ligand 8 (CXCL8), and its receptors C-X-C chemokine receptor (CXCR)1 and CXCR2, in the serum and peritoneal fluid of women with ovarian cancer, and to evaluate the association between the expression of these parameters in tumor tissue and patient characteristics, particularly the degree of histological differentiation. The study group included women with ovarian cancer diagnosed with serous cystadenocarcinoma International Federation of Gynecology and Obstetrics stage IIIc and a control group, which consisted of women who were diagnosed with a benign lesion (serous cystadenoma). The transcript levels of CXCL8, CXCR1 and CXCR2 were evaluated using reverse transcription-quantitative PCR (RT-qPCR). The quantitative analysis was carried out using the LightCycler(®) 480 System and GoTaq(®) 1-Step RT-qPCR System, according to the manufacturers' instructions. The concentration of CXCL8 in serum and peritoneal fluid was determined using a Human Interleukin-8 ELISA kit, and the concentrations of CXCR1 and CXCR2 were determined using the CLOUD-CLONE ELISA kit. Local and systemic disturbances in immune and inflammatory responses involving the CXCL8 chemokine and its receptors indicated the involvement of these studied parameters in the pathogenesis of ovarian cancer. Immunoregulation of the CXCL8-CXCR1 system may influence the course of the inflammatory process accompanying ovarian cancer development, which may result in the identification of novel clinical applications; however, further studies are required. D.A. Spandidos 2022-08-02 /pmc/articles/PMC9435018/ /pubmed/35920183 http://dx.doi.org/10.3892/mmr.2022.12812 Text en Copyright: © Smycz-Kubańska et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Smycz-Kubańska, Marta
Stępień, Sebastian
Gola, Joanna Magdalena
Kruszniewska-Rajs, Celina
Wendlocha, Dominika
Królewska-Daszczyńska, Patrycja
Strzelec, Anna
Strzelczyk, Jarosław
Szanecki, Wojciech
Witek, Andrzej
Mielczarek-Palacz, Aleksandra
Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title_full Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title_fullStr Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title_full_unstemmed Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title_short Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
title_sort analysis of cxcl8 and its receptors cxcr1/cxcr2 at the mrna level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435018/
https://www.ncbi.nlm.nih.gov/pubmed/35920183
http://dx.doi.org/10.3892/mmr.2022.12812
work_keys_str_mv AT smyczkubanskamarta analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT stepiensebastian analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT golajoannamagdalena analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT kruszniewskarajscelina analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT wendlochadominika analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT krolewskadaszczynskapatrycja analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT strzelecanna analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT strzelczykjarosław analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT szaneckiwojciech analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT witekandrzej analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer
AT mielczarekpalaczaleksandra analysisofcxcl8anditsreceptorscxcr1cxcr2atthemrnalevelinneoplastictissueaswellasinserumandperitonealfluidinpatientswithovariancancer